Investigation of Blood Plasma Viral Nucleocapsid Antigen as a Marker of Active Severe Acute Respiratory Syndrome Coronavirus 2 Omicron Variant Infection is a research paper published in Open Forum Infectious Diseases (2023). On theSindex it has a DataRank of 0.292. It has been cited 6 times.
Scored on demand from live citation data
DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?
FAIR checklist signals are shown for context only and do not affect DataRank scoring.
We only score data papers we can read in full — never from an abstract alone.
Base Score Contribution
0.292
From this paper's citation signal
Citation Network Contribution
0
Citation network not refreshed for this result
This paper's DataRank is currently driven only by its base citation score. Citation network data was not refreshed for this result.
Learn more about DataRank methodology →National Institute of Biomedical Imaging and Bioengineering of the National Institutes of Health
Grant: U54EB027690
NIH National Cancer Institute
Grant: U54CA260563
NIH National Center for Advancing Translational Sciences
Grant: UL1TR002378
NHLBI NIH HHS
Grant: T32 HL069769
National Institutes of Health
Grant: 5UL1TR002378-09
Georgia Clinical & Translational Science Alliance (Georgia CTSA)
National Institutes of Health
Grant: 1U54CA260563-01
Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity
National Institutes of Health
Grant: 3U54EB027690-02S1
Emergency COVID-19 supplement for Atlanta Center for Microsystems Engineered Point-of-Care Technoloites (ACME POCT)
Rapid Acceleration of Diagnostics
Marcus Foundation
“Immune Regulation of COVID-19 Infection in Cancer and Autoimmunity”
FWCI
1.01
Citation Percentile
0.7%
Citation Trend
Fields of Study
Keywords
Sustainable Development Goals